Wolverine Trading, LLC Solid Biosciences Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$0.51 - $7.56 $9,945 - $147,420	19,500 New	19,500 $9,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $39,884 - $58,056	-23,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.38 - $3.77 $56,168 - $88,972	23,600 New	23,600 $56,000
Q2 2021 Aug 06, 2021	SELL	$3.49 - $5.51 $88,995 - $140,505	-25,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$5.37 - $10.72 $136,935 - $273,360	25,500 New	25,500 $139,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.